In summary, we developed a GBM-targeted liposomal codelivery system and discovered that α7 nAChRs can be used as a promising delivery target for achieving a ‘three-birds-one-stone’ strategy for action on glioma microenvironment. This evidence concerns the gene CHRNA7 and central nervous system cancer.